Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray
⚠ This medicine appears to have been discontinued
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Lidocaine hydrochloride monohydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
Possible side effects
not listed on this carton. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Apple app or google Play Store. By reporting side effects you can help improve more information on safety of this medicine. Keep all medicines out of the sight and reach of children. Use by the date on the side of the carton. Active ingredient: This oromucosal spray contains Lidocaine Hydrochloride Monohydrate 2% w/v. Also contains: purified water, ethanol (30 vol %), sorbitol (E420), sodium citrate, saccharin, quinoline yellow (E104), patent blue V (E131), flavours (peppermint, levomenthol, aniseed). PL 00014/0430 P Text prepared 03/2025 Manufactured by BCM Ltd Nottingham NG2 3AA for the MAH: The Boots Company PLC Nottingham NG2 3AA Contains approximately 150 sprays. If you need more advice ask your pharmacist. 20 ml e UK Only
Frequently asked questions about Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray
How do I take Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray?
Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray comes as spray. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
What is the active substance in Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray?
The active substance in Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray is lidocaine hydrochloride monohydrate.
Where does this information come from?
This leaflet reproduces the patient information leaflet approved for Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Can I get Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray without a prescription?
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
About this leaflet
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
- Source: electronic medicines compendium (emc), Datapharm
- Active substance: lidocaine hydrochloride monohydrate
- Official document: view the original leaflet on emc →
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
4.1. Therapeutic indications
For the symptomatic relief of severe sore throats.
4.2. Posology and method of administration
Adults and children over 12 years: Three sprays.
Aim nozzle at back of throat and spray on to the affected area. Repeat the dose every three hours as needed up to a maximum of six times in 24 hours.
Children under 12 years: Should not be given to children less than 12 years of age.
Elderly: There is no need for dose reduction in the elderly.
4.3. Contraindications
Hypersensitivity to any of the ingredients. Patients suffering from asthma or bronchospasm. Children under 12 years.
4.4. Special warnings and precautions for use
Do not use if you are sensitive to any of the ingredients.
Avoid contact with the eyes.
Children under 12 years of age should not be given this medicine.
Do not inhale whilst using the spray.
Do not exceed the stated dose.
Keep all medicines out of the reach of children.Seek medical advice if symptoms persist or are accompanied by high fever, headache, nausea or vomiting.Seek medical advice before using this product if you are pregnant, breastfeeding or receiving any medical treatment.
This product may cause numbness of the tongue and therefore care should be taken in eating and drinking hot foods.
Information about some of the ingredients:
This medicine contains 60 mg sorbitol in each 0.40 g dose.
This medicine contains less than 1 mmol sodium (23 mg) per 0.40 g dose, that is to say essentially 'sodium-free'.
This medicine contains 120 mg of alcohol (ethanol) in each 0.40 g dose. The amount in each 0.40 g dose of this medicine is equivalent to less than 6.0 ml beer or 2.4 ml wine.
The small amount of alcohol in this medicine will not have any noticeable effects.
4.5. Interaction with other medicinal products and other forms of interaction
No clinically significant interactions are known.
4.6. Pregnancy and lactation
The safety of this medicinal product for use in human pregnancy has not been established. Experimental animal studies are insufficient to assess the safety with respect to the development of the embryo or foetus, the course of gestation and peri- and post-natal development. The product is, therefore, not recommended during pregnancy and lactation except under medical supervision.
4.7. Effects on ability to drive and use machines
No adverse effects are known.
4.8. Undesirable effects
Occasional hypersensitivity reactions.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4.9. Overdose
Symptoms of overdose include yawning, restlessness, excitement, nervousness, dizziness, nystagmus, tinnitus, blurred vision, nausea, vomiting, muscle twitching, tremors and convulsions. Excitation may be transient and followed by depression with drowsiness, respiratory failure and coma. There may be simultaneous effects on the cardiovascular system with myocardial depression and peripheral vasodilatation, resulting in hypotension, arrhythmias and cardiac arrest.
Very rarely, methaemoglobinaemia may occur with excessive exposure to some local anaesthetics. This is much more commonly seen with benzocaine and prilocaine than with lidocaine. Risk is increased in patients with hereditary methaemoglobinaemia and when used with other oxidising agents.
Treatment consists essentially of maintaining the circulation and respiration and controlling convulsions. The circulation may be maintained with infusions of plasma or suitable electrolyte solutions. Convulsions may be controlled by the intravenous administration of diazepam. If necessary, suxamethonium together with endotracheal intubation and artificial respiration may be used if convulsions persist. Methaemoglobinaemia may be treated by intravenous administration of 1-4 mg/kg methylene blue injection.
🇷🇴 Known in Romania as
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
- LIDOCAINA NORIDEM 10 mg/ml prescriptionLIDOCAINUM · injection / infusion
- LIDOCAINA NORIDEM 20 mg/ml (vezi N01BB02) prescriptionLIDOCAINUM · injection / infusion
- LIDOCAINA KABI 10 mg/ml prescriptionLIDOCAINUM · injection / infusion
- LIVOHEP 20 mg/ml prescriptionLIDOCAINUM · injection / infusion
- LIVOHEP 10 mg/ml prescriptionLIDOCAINUM · injection / infusion
- VERSATIS 700 mg prescriptionLIDOCAINUM · skin / topical
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
🇵🇱 Known in Poland as
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
- Lignocain 2%Lidocaini hydrochloridum · injection / infusion
- Lignocainum JelfaLidocaini hydrochloridum
- Xylocaine 2%Lidocaini hydrochloridum · injection / infusion
- Xylodont 2%Lidocaini hydrochloridum · injection / infusion
- Lidocain-EgisLidocainum · inhaler / nebuliser
- LignoxLidocaini hydrochloridum
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
💬 Ask about this leaflet
Ask anything about Boots Severe Sore Throat Relief 2% w/v Oromucosal Spray. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.